Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05071183
Title A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Turning Point Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 2101 California City California 90033 United States Details
Local Institution - 2109 California City California 92663 United States Details
Local Institution - 2106 Denver Colorado 80218 United States Details
Local Institution - 2108 Nashville Tennessee 37203 United States Details
Local Institution - 2107 Houston Texas 77030 United States Details
Local Institution - 2102 Virginia Beach Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field